Loading the knowledge graph…

Knowledge graph · Cancer

Transplant-Related Hematologic Malignancy

cancer family

Identifier: CI-CAN-00000375
Entity page: /cancer/transplant-related-hematologic-malignancy ↗
Edges: 11

Neighbours: 4 drugs7 trials
Drawn: 11 of 11 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Transplant-Related Hematologic Malignancy investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Cytarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants	—	—	Transplant-Related Hematologic Malignancy	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants

Transplant-Related Hematologic Malignancy studied in …STUDIED_INderived7 of 7
→ studied in	NCT03131934early Phase 1 · completed Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)	—	—	Transplant-Related Hematologic Malignancy	1	Observed	clinicaltrials	graph →
→ studied in	NCT07563010Phase 2 · not yet recruiting Menin-Inhibitor Targeted Maintenance in AML · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)	—	—	Transplant-Related Hematologic Malignancy	1	Observed	clinicaltrials	graph →
→ studied in	NCT04237623Phase 2 · recruiting GM-CSF With Post-Transplant Cyclophosphamide · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)	—	—	Transplant-Related Hematologic Malignancy	1	Observed	clinicaltrials	graph →
→ studied in	NCT03961919Phase 2 · completed Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)	—	—	Transplant-Related Hematologic Malignancy	1	Observed	clinicaltrials	graph →
→ studied in	NCT03434704Phase 2 · completed Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)	—	—	Transplant-Related Hematologic Malignancy	1	Observed	clinicaltrials	graph →
→ studied in	NCT03963024Phase 1 · terminated Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)	—	—	Transplant-Related Hematologic Malignancy	1	Observed	clinicaltrials	graph →
→ studied in	NCT01751243Phase 1 · withdrawn Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)	—	—	Transplant-Related Hematologic Malignancy	1	Observed	clinicaltrials	graph →

Transplant-Related Hematologic Malignancy studied in …STUDIED_INderived7 of 7

→ studied in

NCT03131934early Phase 1 · completed

Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)

—

Observed

clinicaltrials

graph →

→ studied in

NCT07563010Phase 2 · not yet recruiting

Menin-Inhibitor Targeted Maintenance in AML · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)

—

Observed

clinicaltrials

graph →

→ studied in

NCT04237623Phase 2 · recruiting

GM-CSF With Post-Transplant Cyclophosphamide · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)

—

Observed

clinicaltrials

graph →

→ studied in

NCT03961919Phase 2 · completed

Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)

—

Observed

clinicaltrials

graph →

→ studied in

NCT03434704Phase 2 · completed

Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)

—

Observed

clinicaltrials

graph →

→ studied in

NCT03963024Phase 1 · terminated

Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)

—

Observed

clinicaltrials

graph →

→ studied in

NCT01751243Phase 1 · withdrawn

Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 7 trials mapped (2 active)

—

Observed

clinicaltrials

graph →

Radial view

Every edge, grouped by relationship

Strongest chains